NPR, Inter Press Service Examine Efforts To Prevent Drug-Resistant Malaria

As part of its continuing coverage of malaria, NPR’s “Shots” blog features a story on counterfeit anti-malarial drugs, which “are among the most popular drugs to fake.” According to the blog, “[T]hese faux pharmaceuticals are particularly dangerous because malaria can kill a person in a matter of days,” and, if the drugs contain only a small amount of the real drug, they can contribute to the development of drug-resistant malaria parasites. “And that appears to be happening now in Southeast Asia with one of the most powerful anti-malarials, artemisinin,” the blog writes (Beaubien, 12/19).

In related news, Inter Press Service examines efforts to track and treat drug-resistant malaria along the Thai-Myanmar border. Fatoumata Nafo-Traore, head of the Roll Back Malaria Partnership, said, “We need to contain the resistance in these local areas. … This has to be seen as a global concern because there is no other highly effective anti-malaria drug than artemisinin therapy,” according to the news service. IPS highlights the need for sustained funding to contain the spread of drug-resistant malaria in the region (Macan-Markar, 12/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.